The Optic Neuritis Treatment Market is developing as healthcare providers and researchers focus on improving the management of optic nerve inflammation and related vision problems. Optic neuritis can be associated with inflammatory and neurological conditions, creating demand for timely diagnosis and appropriate treatment approaches.

Treatment options include corticosteroids, plasma exchange therapy, intravenous immunoglobulin therapy, and monoclonal antibodies. The market is also segmented according to routes of administration, including oral, intravenous, and subcutaneous methods.

Growing awareness of optic neuritis and improvements in neurological and ophthalmic care are supporting market development. Advances in diagnostic technologies are also helping healthcare professionals identify optic nerve abnormalities and make more informed treatment decisions.

Research into biologics, immunotherapies, and other targeted approaches is creating additional opportunities for pharmaceutical companies and healthcare technology providers. At the same time, improvements in healthcare infrastructure are helping expand access to specialized treatment in developing markets.

According to Wise Guy Reports, the market is projected to expand during 2026–2035, with technological progress, increasing awareness, and demand for innovative therapies identified among the factors influencing future development.